Taurochenodeoxycholic acid API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Taurochenodeoxycholic acid API 516-35-8?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Taurochenodeoxycholic acid. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Taurochenodeoxycholic acid
- Synonyms:
- Chenodeoxycholoyltaurine , Taurine chenodeoxycholate , Taurochenodeoxycholate , Taurochenodeoxycholic acid
- Cas Number:
- 516-35-8
- DrugBank number:
- DB08833
- Unique Ingredient Identifier:
- 651KU15938
General Description:
Taurochenodeoxycholic acid, identified by CAS number 516-35-8, is a notable compound with significant therapeutic applications. Taurochenodeoxycholic acid is an experimental drug that is normally produced in the liver. Its physiologic function is to emulsify lipids such as cholesterol in the bile. As a medication, taurochenodeoxycholic acid reduces cholesterol formation in the liver, and is likely used as a choleretic to increase the volume of bile secretion from the liver and as a cholagogue to increase bile discharge into the duodenum. It is also being investigated for its role in inflammation and cancer therapy.
Indications:
This drug is primarily indicated for: Taurochenodeoxycholic acid is likely indicated as a choleretic and cholagogue. It is also being investigated for its role in inflammation and cancer therapy. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Mechanism of Action:
Taurochenodeoxycholic acid functions by: Chenodeoxycholic acid is a primary bile acid in the liver that combines with taurine to form the bile acid taurochenodeoxycholic acid. In the bile, taurochenodeoxycholic acid is either a sodium (most) or potassium salt. Taurochenodeoxycholic acid is normally produced in the liver, and its physiologic function as a bile salt is to emulsify lipids such as cholesterol in the bile. As a medication, taurochenodeoxycholic acid reduces cholesterol formation in the liver, and is likely used as a choleretic to increase the volume of bile secretion from the liver and as a cholagogue to increase bile discharge into the duodenum. The mechanism of action of taurochenodeoxycholic acid in inflammation and cancer has yet to be determined. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.
Classification:
Taurochenodeoxycholic acid belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety, classified under the direct parent group Taurinated bile acids and derivatives. This compound is a part of the Organic compounds, falling under the Lipids and lipid-like molecules superclass, and categorized within the Steroids and steroid derivatives class, specifically within the Bile acids, alcohols and derivatives subclass.
Categories:
Taurochenodeoxycholic acid is categorized under the following therapeutic classes: Alkanes, Alkanesulfonic Acids, Bile Acids and Salts, Cholagogues and Choleretics, Cholanes, Cholic Acids, Compounds used in a research, industrial, or household setting, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Detergents, Fused-Ring Compounds, Gastrointestinal Agents, Household Products, Hydrocarbons, Acyclic, Steroids, Sulfonic Acids, Sulfur Acids, Sulfur Compounds, Surface-Active Agents, Taurodeoxycholic Acid. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Taurochenodeoxycholic acid is a type of Anticancer drugs
Anticancer drugs belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category designed specifically to combat cancer cells. These powerful medications play a crucial role in cancer treatment and are developed to target and destroy cancerous cells, preventing their growth and spread.
Anticancer drugs are classified based on their mode of action and can include various types such as chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormonal therapy drugs. Chemotherapy drugs work by interfering with the cell division process, thereby inhibiting the growth of cancer cells. Targeted therapy drugs, on the other hand, are designed to attack specific molecules or genes involved in cancer growth, minimizing damage to healthy cells. Immunotherapy drugs stimulate the body's immune system to recognize and destroy cancer cells. Hormonal therapy drugs are used in cancers that are hormone-dependent, such as breast or prostate cancer, to block the hormones that fuel cancer cell growth.
These APIs are typically synthesized through complex chemical processes in state-of-the-art manufacturing facilities. Stringent quality control measures ensure the purity, potency, and safety of these drugs. Anticancer APIs undergo rigorous testing and adhere to stringent regulatory guidelines before being approved for clinical use.
Due to their critical role in cancer treatment, anticancer drugs are in high demand worldwide. Researchers and pharmaceutical companies continually strive to develop new and more effective APIs in this category to enhance treatment outcomes and minimize side effects. The ongoing advancements in the field of anticancer drug development offer hope for improved cancer therapies and better patient outcomes.
